Stockholm (HedgeNordic) – Danish hedge fund Nykredit MIRA received the EuroHedge Award for Europe’s best fixed-income hedge fund of 2017, an award handed out at the 17th annual EuroHedge Awards event held in London earlier this week. The list of nominees for the fixed-income category was dominated by Nordic hedge funds, with five of the six contenders being members of the NHX.

Nykredit MIRA, a relative value fund investing in fixed-income instruments with a focus on Danish mortgage bonds, was the best-performing fund of 2017 within the NHX Fixed Income Index. The fund managed by Nykredit Asset Management gained 18.1% last year, recording its second-best yearly performance since its inception in late 2008. Nykredit MIRA generated returns of equal magnitude in the prior year, with the fund up 16.7% in 2016.

Nykredit KOBRA, the other fixed-income hedge fund managed by Nykredit Asset Management, Asgard Fixed Income, Borea European Credit, and Danske Invest Hedge Fixed Income Strategies were among the six nominees in the fixed-income category. Healthcare-focused Rhenman Healthcare Equity L/S, with an appreciation of 34.5% the best-performing Nordic hedge fund of 2017, was among the nominees in the “Specialist Sector Equity” category for EuroHedge Awards 2017. This category includes funds that focus exclusively on a specific sector or group of sectors such as financials, real estate, healthcare, technology or energy, for example.

 

Picture © Grossartiger – Shutterstock

Print Friendly, PDF & Email
The following two tabs change content below.

Eugeniu Guzun

Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index (NHX), as well as being a novice columnist covering the Nordic hedge fund industry for HedgeNordic. Prior tojoining the HedgeNordic team, Eugeniu had served as a columnist for a “niche” U.S. journal covering insider trading activity, activist campaigns and hedge fund moves. Eugeniu is currently pursuing a Master’s degree at the Stockholm School of Economics.

Leave a Reply

Your email address will not be published.

Time limit is exhausted. Please reload CAPTCHA.